Masimo Corp. (MASI)

116.17
0.18 0.16
NASDAQ : Health Technology
Prev Close 115.99
Open 115.98
Day Low/High 115.72 / 118.00
52 Wk Low/High 80.69 / 126.89
Volume 534.47K
Avg Volume 451.50K
Exchange NASDAQ
Shares Outstanding 53.00M
Market Cap 5.90B
EPS 2.50
P/E Ratio 43.15
Div & Yield N.A. (N.A)

Latest News

Masimo To Present At 37th Annual J.P. Morgan Healthcare Conference

Masimo To Present At 37th Annual J.P. Morgan Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 37th Annual J.

Masimo Founder And CEO Joe Kiani Speaking At The 2018 IPO Education Foundation Awards Dinner (Photo: Business Wire)

Masimo Founder And CEO Joe Kiani Speaking At The 2018 IPO Education Foundation Awards Dinner (Photo: Business Wire)

Masimo (NASDAQ: MASI) Founder and CEO Joe Kiani was honored last night at the 2018 IPO Education Foundation Awards Dinner with the first ever IP Champion Award.

Technically Attractive Masimo Looks Ready for a Rally Back to the Highs

Technically Attractive Masimo Looks Ready for a Rally Back to the Highs

Traders could go long Masimo at current levels and on strength above $113.

This Market is Treacherous: Cramer's 'Mad Money' Recap (Thursday 12/11/18)

This Market is Treacherous: Cramer's 'Mad Money' Recap (Thursday 12/11/18)

Tuesday's wild market ride was all about China, Jim Cramer says.

Masimo Rad-67™ With SpHb® (Photo: Business Wire)

Masimo Rad-67™ With SpHb® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient blood management, which includes clear guidance on the use...

Masimo To Present At Stifel 2018 Healthcare Conference

Masimo To Present At Stifel 2018 Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Stifel 2018 Healthcare Conference at the Palace Hotel in New York on Wednesday, November 14, 2018 at 10:15 a.

Masimo Reports Third Quarter 2018 Financial Results

Masimo Reports Third Quarter 2018 Financial Results

Masimo (NASDAQ: MASI) today announced its financial results for the third quarter ended September 29, 2018.

Masimo Radical-7® With RD SET™ Sensor And SET® Pulse Oximetry (Photo: Business Wire)

Masimo Radical-7® With RD SET™ Sensor And SET® Pulse Oximetry (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that RD SET™ sensors with Masimo Measure-through Motion and Low Perfusion™ SET ® pulse oximetry have received FDA clearance with improved SpO 2 accuracy specifications for all patients > 3 kg.

Masimo To Report Third Quarter 2018 Financial Results After Market Close On Wednesday, October 31

Masimo To Report Third Quarter 2018 Financial Results After Market Close On Wednesday, October 31

Masimo (NASDAQ: MASI) announced today that it will release third quarter 2018 financial results for the period ended September 29, 2018, after the market closes on Wednesday, October 31, 2018.

Masimo Patient SafetyNet™, Root®, Radius-7®, Radical-7®, And Replica™ (Photo: Business Wire)

Masimo Patient SafetyNet™, Root®, Radius-7®, Radical-7®, And Replica™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that Bassett Medical Center, a 180-bed Cooperstown, New York hospital, has adopted Masimo Patient SafetyNet™ and Root ® with Vital Signs Check across its 54-bed medical-surgical unit, including pediatric beds.

Masimo Root® With Radical-7®, ORi™, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo Root® With Radical-7®, ORi™, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation (SFAR) in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™...

Masimo To Present At Morgan Stanley 16th Annual Global Healthcare Conference

Masimo To Present At Morgan Stanley 16th Annual Global Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt Hotel in New York on Thursday, September 13, 2018 at 1:30 p.

Masimo Root® With Radical-7®, RRa®, And The RAS-45 Infant/Neonatal Sensor (Photo: Business Wire)

Masimo Root® With Radical-7®, RRa®, And The RAS-45 Infant/Neonatal Sensor (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today FDA clearance of RAS-45, an acoustic respiration sensor for rainbow Acoustic Monitoring ® (RAM ®), for infant and neonatal patients.

Masimo Radical-7® With PVi® (Photo: Business Wire)

Masimo Radical-7® With PVi® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in which researchers at University Hospital Linköping, Sweden, compared the performance of goal-directed fluid therapy (GDFT) using invasive esophageal...

Masimo Root® With Radical-7® And ORi™ (Photo: Business Wire)

Masimo Root® With Radical-7® And ORi™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the Netherlands, and Ghent University, Belgium, investigated the ability of Masimo ORi™ (Oxygen...

Masimo Radical-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo Radical-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) -...

H Michael Cohen Joins Masimo's Board Of Directors

H Michael Cohen Joins Masimo's Board Of Directors

Masimo (NASDAQ: MASI), a global medical technology developer and manufacturer of innovative noninvasive patient monitoring technologies, announced today that H Michael Cohen, former Vice Chairman of Healthcare Investment Banking at Deutsche Bank...

Masimo Reports Second Quarter 2018 Financial Results And Announces Board Authorization Of A New Stock Repurchase Program

Masimo Reports Second Quarter 2018 Financial Results And Announces Board Authorization Of A New Stock Repurchase Program

Masimo (NASDAQ: MASI) today announced its financial results for the second quarter ended June 30, 2018.

Masimo Radius-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo Radius-7® Pulse CO-Oximeter® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Dartmouth-Hitchcock Medical Center investigated the impact of an integrated clinical monitoring system, using various Masimo technologies and devices,...

Masimo To Report Second Quarter 2018 Financial Results After Market Close On Wednesday, August 1

Masimo To Report Second Quarter 2018 Financial Results After Market Close On Wednesday, August 1

Masimo (NASDAQ: MASI) announced today that it will release second quarter 2018 financial results for the period ended June 30, 2018, after the market closes on Wednesday, August 1, 2018.

Masimo Radical-7® With PVi®, SpHb®, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo Radical-7® With PVi®, SpHb®, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to goal-directed fluid management (GDFM) using Masimo PVi...

Masimo Root® Vital Signs Check (Photo: Business Wire)

Masimo Root® Vital Signs Check (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the worldwide release of the Vital Signs Check Application, an integrated patient data collection and workflow application for the Masimo Root ® patient monitoring and connectivity platform.

Masimo Root® With Radical-7® And ORi™ (Photo: Business Wire)

Masimo Root® With Radical-7® And ORi™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a study in which researchers evaluated the ability of Masimo ORi™ (Oxygen Reserve Index) to detect declining blood oxygenation prior to standard oxygen saturation (SpO 2) monitoring in patients...

Masimo Rad-97™ With Eve™ (Photo: Business Wire)

Masimo Rad-97™ With Eve™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that the United Arab Emirates (UAE) Ministry of Health & Prevention (MOHAP) is adopting a national screening protocol for critical congenital heart disease (CCHD) for all newborns.

Masimo TIR-1™ (Photo: Business Wire)

Masimo TIR-1™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) and Thermomedics, a PositiveID (OTCQB: PSID) company, announced today the debut and U.

Masimo Root® With SedLine® PSi And O3® Regional Oximetry (Photo: Business Wire)

Masimo Root® With SedLine® PSi And O3® Regional Oximetry (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo Patient State Index (PSi), a processed EEG parameter provided by SedLine ® brain function monitoring (in this study,...

Masimo Root® With Radical-7® And SpHb® (Photo: Business Wire)

Masimo Root® With Radical-7® And SpHb® (Photo: Business Wire)

Masimo (NASDAQ:MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb ®) to intermittent and invasive lab hemoglobin (LabHb) in reflecting...

Andrea Hlaváčková (Photo: Business Wire)

Andrea Hlaváčková (Photo: Business Wire)

The Women's Tennis Association (WTA) and Masimo (NASDAQ: MASI) announced today that the WTA's Sport Sciences and Medicine (SS&M) team will immediately begin using Masimo MightySat™ as part of their mission to provide comprehensive care for athletes on the...

TheStreet Quant Rating: B (Buy)